Author

Albert Jan Bredenoord 1

1 Academisch M

A 12-WEEK TREATMENT WITH BUDESONIDE ORODISPERSIBLE TABLETS IN THE EOS-1 TRIAL FOR INCOMPLETE RESPONDERS SIGNIFICANTLY IMPROVES BOTH INFLAMMATORY AND FIBROSTENOTIC ENDOSCOPIC FEATURES IN ADULT PATIENTS WITH ACTIVE EOSINOPHILIC ESOPHAGITIS

Stephan Miehlke, Alfredo J. Lucendo, Christoph Schlag, Ulrike von Arnim, Javier Molina Infante, Christoph Schmöcker, Albert Jan Bredenoord, Constanza Ciriza De Los Ríos, Stefan Brückner, Ahmed Madisch, Stefan Schubert, Jamal Hayat, Stephen E. Attwood, Jan Tack, Ralph Mueller, Roland Greinwald, Alex Straumann, Alain M. Scho

BUDESONIDE ORODISPERSIBLE TABLETS ARE HIGHLY EFFECTIVE FOR RE-INDUCTION OF CLINICAL REMISSION IN RELAPSING ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE EOS-2 TRIAL

Christoph Schlag, Alex Straumann, Alfredo J. Lucendo, Stephan Miehlke, Luc Biedermann, Cecilio Santander Vaquero, Constanza Ciriza De Los Ríos, Christoph Schmöcker, Ahmed Madisch, Petr Hruz, Jamal Hayat, Ulrike von Arnim, Albert Jan Bredenoord, Ralph Mueller, Roland Greinwald, Alain M. Schoepfer, Stephen E. Attwood, Stefan

Item 1 - 2 / 2
1